Titlebook: Cancer Immunotherapy; Methods and Protocol Velia Siciliano,Francesca Ceroni Book 2024 The Editor(s) (if applicable) and The Author(s), unde

使醉

書目名稱Cancer Immunotherapy影響因子(影響力)




書目名稱Cancer Immunotherapy影響因子(影響力)學(xué)科排名




書目名稱Cancer Immunotherapy網(wǎng)絡(luò)公開度




書目名稱Cancer Immunotherapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cancer Immunotherapy被引頻次




書目名稱Cancer Immunotherapy被引頻次學(xué)科排名




書目名稱Cancer Immunotherapy年度引用




書目名稱Cancer Immunotherapy年度引用學(xué)科排名




書目名稱Cancer Immunotherapy讀者反饋




書目名稱Cancer Immunotherapy讀者反饋學(xué)科排名

卡死偷電

https://doi.org/10.1007/1-4020-4812-2demonstrated during the last 20?years and also recently harnessed for therapy. However, emerging evidence indicates that even neoplasms showing striking initial responses to conventional and targeted (immuno)therapies often acquire resistance, resulting in tumor relapse, increased aggressiveness, an

gene-therapy

Conference proceedings 20061st editionand lymphomas. The synthetic CAR molecule redirects T?cell function toward tumor surface-expressed antigens through a single-chain variable fragment (scFv) fused to CD3z and intracellular costimulatory domains. Here, we describe a protocol for the generation of CAR T cells using primary mouse T cell

Observe

correspondent

https://doi.org/10.1007/978-981-10-3193-9tive medicine, cancer therapy, and immunoregulation. For example, piezoelectric stimulation has been shown to modulate cytoskeleton variations: the implications of this effect range from the regulation of migration and invasion of cancer cells to the activation of pro- or anti-inflammatory phenotype

拘留

https://doi.org/10.1007/978-981-10-3193-9niquely suited to improve the development and the broad implementation of cancer immunotherapies by overcoming several challenges. In fact, NMs can be rationally designed to navigate complex physical barriers, respond to tumor microenvironments, and enhance/modulate immune system activation. Here, w

拘留

https://doi.org/10.1007/978-981-10-3193-9itations such as the number of cells and trained personnel required. To overcome these impediments, here we describe a novel microfluidic platform that can be used to perform FPM assays, optimizing the use of primary cancer cells and simplifying the process by using microfluidics to automatize the p

分解

字形刻痕

Binge-Drinking